Erlanger Health System — research payments reported

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$12,250	2
2022	Research	$1,135	1
2019	Research	$37,474	9

Breakdown

Who paid Research payments · program years 2019–2023

Medtronic USA, Inc. $36,175 8 payments
Cordis US Corp. $12,250 2 payments
Allergan Inc. $1,299 1 payment
Boston Scientific Corporation $1,135 1 payment

Studies the money was for Research payments · program years 2019–2023

SNM Trial Phase Study $36,175 8 payments
A Multicenter, Prospective, Randomized, Controlled, Open Label Trial to Evaluate the Safety and Efficacy of Mynx Control Venous Vascular Closure Device 6F-12F VS. Manual Compression in Patients Who Have Undergone Endovascular Procedures Utilizing Up to 12F Procedural Sheaths $12,250 2 payments
A Phase 2B Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Medi2070 in Subjects With Moderate to Severe Crohn's Disease Who Have Failed Or Are Intolerant to Anti-Tumor Necrosis Factor-Alpha Therapy $1,299 1 payment
Lux-Dx Perform $1,135 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.